Institutional & Family Asset Management’s GraniteShares Gold Shares BAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-371
Closed -$6K 726
2022
Q3
$6K Hold
371
﹤0.01% 438
2022
Q2
$7K Hold
371
﹤0.01% 428
2022
Q1
$7K Hold
371
﹤0.01% 480
2021
Q4
$7K Sell
371
-500
-57% -$8.91K ﹤0.01% 492
2021
Q3
$15K Hold
871
﹤0.01% 484
2021
Q2
$15K Hold
871
﹤0.01% 515
2021
Q1
$15K Hold
871
﹤0.01% 512
2020
Q4
$16K Sell
871
-619
-42% -$11.5K ﹤0.01% 465
2020
Q3
$28K Hold
1,490
0.01% 356
2020
Q2
$26K Hold
1,490
0.01% 372
2020
Q1
$23K Hold
1,490
0.01% 355
2019
Q4
$23K Hold
1,490
﹤0.01% 413
2019
Q3
$22K Hold
1,490
﹤0.01% 389
2019
Q2
$21K Sell
1,490
-340
-19% -$4.44K ﹤0.01% 417
2019
Q1
$24K Buy
1,830
+1,010
+123% +$13.1K 0.01% 404
2018
Q4
$10K Hold
820
﹤0.01% 468
2018
Q3
$10K Hold
820
﹤0.01% 527
2018
Q2
$10K Buy
+820
New +$10.7K ﹤0.01% 523

Other funds holding BAR

Institutional & Family Asset Management's BAR Position: Q4 2022 in Review

Institutional & Family Asset Management sold out of GraniteShares Gold Shares (BAR) in Q4 2022, closing a stake of 371 shares — an estimated $6K sold.

Institutional & Family Asset Management first reported a position in BAR in Q2 2018 and held it in 18 quarters. The position peaked at $28K in Q3 2020. 114 funds tracked by Wall St. Rank hold BAR as of Q4 2022.

  • Institutional & Family Asset Management reported no remaining GraniteShares Gold Shares position as of Q4 2022 after selling out during the quarter.
  • Institutional & Family Asset Management sold 371 GraniteShares Gold Shares shares in Q4 2022, an estimated $6K.
  • Institutional & Family Asset Management first reported a position in GraniteShares Gold Shares in Q2 2018 and held it in 18 quarters.
  • Institutional & Family Asset Management's GraniteShares Gold Shares position peaked at $28K in Q3 2020.
  • 114 funds tracked by Wall St. Rank held GraniteShares Gold Shares as of Q4 2022.

Based on Institutional & Family Asset Management's 13F filing for Q4 2022, filed 8 Feb 2023.